MeMed

Deepull

Deepull develops automated diagnostic systems that identify pathogens and antibiotic resistance directly from blood samples for healthcare providers treating sepsis and acute infections.

Resistell

This company develops nanomotion-based diagnostic platforms for rapid antibiotic susceptibility testing to help healthcare providers and laboratories treat bloodstream infections.

Inbiome

Inbiome develops molecular diagnostic platforms for rapid bacterial identification to support healthcare providers, pharmaceutical companies and military medical units in treating infections.

iFAST Diagnositcs

The company develops rapid antimicrobial susceptibility testing systems for hospitals and clinical laboratories to identify effective antibiotic treatments for bacterial infections.

ShanX

ShanX Medtech develops in-vitro diagnostic platforms for rapid antibiotic susceptibility testing to help clinicians treat bacterial infections in point-of-care and laboratory settings.

Pictura Bio

This company develops point-of-care diagnostic tools using machine learning and microscopy to identify pathogens in respiratory samples for clinicians and healthcare providers.

Videm

Videm develops a handheld diagnostic device for rapid molecular and protein detection of infectious diseases in care settings and at home.

Presymptom Health

This company develops AI-driven diagnostic tests and software that detect infection and sepsis in patients for use by healthcare providers and clinical labs.